TY  - JOUR
AU  - Dagher, Alain
AU  - Palomero-Gallagher, Nicola
TI  - Mapping dopamine with positron emission tomography: A note of caution
JO  - NeuroImage
VL  - 207
SN  - 1053-8119
CY  - Orlando, Fla.
PB  - Academic Press
M1  - FZJ-2019-06626
SP  - 116203 -
PY  - 2020
AB  - Positron emission tomography (PET) imaging is uniquely suited to measuring neurotransmitter signaling in the human brain. PET tracers for neurotransmitter studies are ligands of the receptor or enzyme of interest labelled with positron emitting isotopes, usually 11C of 18F. By far the most frequent target of PET neurotransmitter imaging is dopamine, and the most commonly used tracer is [11C]raclopride, an antagonist of the dopamine D2 receptor (D2R), first developed by researchers at the Karolinska Institute (Farde et al., 1986).
LB  - PUB:(DE-HGF)16
C6  - pmid:31539589
UR  - <Go to ISI:>//WOS:000509662600032
DO  - DOI:10.1016/j.neuroimage.2019.116203
UR  - https://juser.fz-juelich.de/record/868033
ER  -